MANGANESE SULFATE

N/A

Manufactured by BM Private Limited

450 FDA adverse event reports analyzed

Last updated: 2026-04-15

About MANGANESE SULFATE

MANGANESE SULFATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by BM Private Limited. The most commonly reported adverse reactions for MANGANESE SULFATE include THROMBOCYTOPENIA, RESPIRATORY TRACT INFECTION, RESPIRATORY TRACT INFECTION VIRAL, COVID-19, RESPIRATORY TRACT INFECTION BACTERIAL. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MANGANESE SULFATE.

Top Adverse Reactions

THROMBOCYTOPENIA26 reports
RESPIRATORY TRACT INFECTION24 reports
RESPIRATORY TRACT INFECTION VIRAL24 reports
COVID 1923 reports
RESPIRATORY TRACT INFECTION BACTERIAL23 reports
PULMONARY EMBOLISM22 reports
PLATELET COUNT DECREASED20 reports
ANAEMIA16 reports
NEUTROPENIA16 reports
INTENTIONAL PRODUCT USE ISSUE15 reports
MALAISE8 reports
ASTHENIA7 reports
CHILLS7 reports
DEATH7 reports
NAUSEA7 reports
CONDITION AGGRAVATED6 reports
PYREXIA6 reports
URINARY TRACT INFECTION6 reports
VOMITING6 reports
CHRONIC OBSTRUCTIVE PULMONARY DISEASE5 reports
DRUG INEFFECTIVE5 reports
DRUG INTERACTION5 reports
FATIGUE5 reports
PAIN5 reports
BONE EROSION4 reports
DRUG HYPERSENSITIVITY4 reports
GAIT INABILITY4 reports
GENERAL PHYSICAL HEALTH DETERIORATION4 reports
HEPATIC ENZYME ABNORMAL4 reports
INFECTION4 reports
MOBILITY DECREASED4 reports
NEUROPATHY PERIPHERAL4 reports
OSTEOARTHRITIS4 reports
PAIN IN EXTREMITY4 reports
RHEUMATOID ARTHRITIS4 reports
URINE ABNORMALITY4 reports
URINE ODOUR ABNORMAL4 reports
WEIGHT DECREASED4 reports
ARTHRALGIA3 reports
DIZZINESS3 reports
FALL3 reports
FULL BLOOD COUNT ABNORMAL3 reports
OFF LABEL USE3 reports
PNEUMONIA3 reports
PRODUCT PRESCRIBING ERROR3 reports
WHITE BLOOD CELL COUNT DECREASED3 reports
ABDOMINAL PAIN UPPER2 reports
BACK PAIN2 reports
CONTRAINDICATED PRODUCT ADMINISTERED2 reports
DECREASED APPETITE2 reports
DEHYDRATION2 reports
DIARRHOEA2 reports
DIVERTICULUM2 reports
EYE SWELLING2 reports
FEELING ABNORMAL2 reports
GASTROINTESTINAL HAEMORRHAGE2 reports
HYPERTENSION2 reports
HYPOTENSION2 reports
LOSS OF CONSCIOUSNESS2 reports
MYOCARDIAL INFARCTION2 reports
PALPITATIONS2 reports
POSTOPERATIVE WOUND INFECTION2 reports
PRODUCT DOSE OMISSION ISSUE2 reports
RASH2 reports
THROMBIN TIME PROLONGED2 reports
TREMOR2 reports
VISION BLURRED2 reports
WHEELCHAIR USER2 reports
ABDOMINAL DISCOMFORT1 reports
ABDOMINAL WALL HAEMATOMA1 reports
ACUTE GRAFT VERSUS HOST DISEASE1 reports
ACUTE HEPATIC FAILURE1 reports
AFFECTIVE DISORDER1 reports
ANAPHYLACTIC REACTION1 reports
ANXIETY1 reports
ARTHRITIS1 reports
ARTHROPATHY1 reports
ARTHROPOD BITE1 reports
ATRIAL FIBRILLATION1 reports
AUTISM SPECTRUM DISORDER1 reports
AUTOIMMUNE DISORDER1 reports
BENIGN NEOPLASM1 reports
BIOPSY LIVER1 reports
BLOOD ALBUMIN DECREASED1 reports
BLOOD IRON DECREASED1 reports
BLOOD LACTATE DEHYDROGENASE INCREASED1 reports
BLOOD POTASSIUM DECREASED1 reports
BLOOD PRESSURE ABNORMAL1 reports
BLOOD PRESSURE DECREASED1 reports
BLOOD TEST ABNORMAL1 reports
BODY TEMPERATURE INCREASED1 reports
BRAIN NEOPLASM1 reports
BRAIN STEM SYNDROME1 reports
BREAST CANCER1 reports
BRONCHIECTASIS1 reports
CARDIAC FAILURE CONGESTIVE1 reports
CARDIOMEGALY1 reports
CATARACT1 reports
CEPHALHAEMATOMA1 reports
CEREBRAL ATROPHY1 reports

Report Outcomes

Out of 78 classified reports for MANGANESE SULFATE:

Serious 84.6%Non-Serious 15.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male42 (58.3%)
Female30 (41.7%)

Reports by Age

Age 7422 reports
Age 625 reports
Age 754 reports
Age 613 reports
Age 272 reports
Age 602 reports
Age 702 reports
Age 722 reports
Age 321 reports
Age 331 reports
Age 351 reports
Age 391 reports
Age 501 reports
Age 541 reports
Age 561 reports
Age 631 reports
Age 641 reports
Age 671 reports
Age 681 reports
Age 731 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with MANGANESE SULFATE?

This profile reflects 450 FDA FAERS reports that mention MANGANESE SULFATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for MANGANESE SULFATE?

Frequently reported terms in FAERS include THROMBOCYTOPENIA, RESPIRATORY TRACT INFECTION, RESPIRATORY TRACT INFECTION VIRAL, COVID-19, RESPIRATORY TRACT INFECTION BACTERIAL, PULMONARY EMBOLISM. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures MANGANESE SULFATE?

Labeling and FAERS entries often list BM Private Limited in connection with MANGANESE SULFATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.